Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 451826, 7 pages
http://dx.doi.org/10.1155/2014/451826
Research Article

Protective Effects of Pretreatment with Oleanolic Acid in Rats in the Acute Phase of Hepatic Ischemia-Reperfusion Injury: Role of the PI3K/Akt Pathway

1Department of Anesthesiology, 1st Affiliated Hospital, Nanjing Medical University, Nanjing, China
2Key laboratory of Anesthesiology, Xuzhou, Jiangsu, China
3Department of Anesthesiology, 2rd Affiliated Hospital, Nanchang University, Nanchang, China
4Department of Emergency, 1st Affiliated Hospital, Nanjing Medical University, Nanjing, China
5Department of Anesthesiology, Jiangsu Tumor Hospital, Nanjing, China
6Center for Drug Discovery, College of Pharmacy, China Pharmaceutical University, Nanjing, China

Received 6 February 2014; Revised 26 March 2014; Accepted 31 March 2014; Published 16 April 2014

Academic Editor: KyungHyun Kim

Copyright © 2014 Bo Gui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Pérez-Camino and A. Cert, “Quantitative determination of hydroxy pentacyclic triterpene acids in vegetable oils,” Journal of Agricultural and Food Chemistry, vol. 47, no. 4, pp. 1558–1562, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. D. W. Han, X. H. Ma, Y. C. Zhao, L. Yin, and C. X. Ji, “Studies on the preventive action of oleanolic acid on experimental cirrhosis,” Journal of Traditional Chinese Medicine, vol. 2, no. 2, pp. 83–90, 1982. View at Google Scholar · View at Scopus
  3. J. Liu, “Oleanolic acid and ursolic acid: research perspectives,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 92–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Liu, Y. Liu, and C. D. Klaassen, “The effect of Chinese hepatoprotective medicines on experimental liver injury in mice,” Journal of Ethnopharmacology, vol. 42, no. 3, pp. 183–191, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Liu, Y. Liu, A. Parkinson, and C. D. Klaassen, “Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 275, no. 2, pp. 768–774, 1995. View at Google Scholar · View at Scopus
  6. E. E. Montalvo-Jave, T. Escalante-Tattersfield, J. A. Ortega-Salgado, E. Piña, and D. A. Geller, “Factors in the Pathophysiology of the Liver Ischemia-Reperfusion Injury,” Journal of Surgical Research, vol. 147, no. 1, pp. 153–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Dahmen, A. Liu, H. Jin et al., “Release of danger signals during ischemic storage of the liver: a potential marker of organ damage?” Mediators of Inflammation, vol. 2010, Article ID 436145, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. J. Kloek, X. Maréchal, J. Roelofsen et al., “Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion,” Antioxidants & Redox Signaling, vol. 17, no. 8, pp. 1109–1123, 2012. View at Google Scholar
  9. S. O. Cho, J. Y. Ban, J. Y. Kim et al., “Anti-ischemic activities of aralia cordata and its active component, oleanolic acid,” Archives of Pharmacal Research, vol. 32, no. 6, pp. 923–932, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Du and K. M. Ko, “Oleanolic acid protects against myocardial ischemia-reperfusion injury by enhancing mitochondrial antioxidant mechanism mediated by glutathione and α-tocopherol in rats,” Planta Medica, vol. 72, no. 3, pp. 222–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Gui, M. Su, J. Chen, L. Jin, R. Wan, and Y. Qian, “Neuroprotective effects of pretreatment with propofol in LPS-induced BV-2 microglia cells: role of TLR4 and GSK-3β,” Inflammation, vol. 35, no. 5, pp. 1632–1640, 2012. View at Google Scholar
  12. S. Puangpraphant, V. P. Dia, E. G. de Mejia, G. Garcia, M. A. Berhow, and M. A. Wallig, “Yerba mate tea and mate saponins prevented azoxymethane-induced inflammation of rat colon through suppression of NF-κB p65ser (311) signaling via IκB-α and GSK-3β reduced phosphorylation,” Biofactors, vol. 39, no. 4, pp. 430–440, 2013. View at Google Scholar
  13. A. T. Varela, A. M. Simões, J. S. Teodoro et al., “Indirubin-3′-oxime prevents hepatic I/R damage by inhibiting GSK-3β and mitochondrial permeability transition,” Mitochondrion, vol. 10, no. 5, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. J. Kim, Y. Joe, J. S. Kong et al., “Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 306421, 11 pages, 2013. View at Publisher · View at Google Scholar
  15. M. Taniguchi, M. Uchinami, K. Doi et al., “Edaravone reduces ischemia-reperfusion injury mediators in rat liver,” Journal of Surgical Research, vol. 137, no. 1, pp. 69–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. G. Jeong, “Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury,” Toxicology Letters, vol. 105, no. 3, pp. 215–222, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Yun, H. I. Cho, and S. M. Lee, “Impaired autophagy contributes to hepatocellular damage during ischemia/reperfusion: heme oxygenase-1 as a possible regulator,” Free Radical Biology & Medicine, vol. 68, pp. 168–177, 2014. View at Google Scholar
  18. T. Yajima, H. Nishimura, K. Saito, H. Kuwano, and Y. Yoshikai, “Overexpression of interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guérin,” Infection and Immunity, vol. 72, no. 7, pp. 3855–3862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Liaskou, D. V. Wilson, and Y. H. Oo, “Innate immune cells in liver inflammation,” Mediators Inflamm, vol. 2012, Article ID 949157, 21 pages, 2012. View at Publisher · View at Google Scholar
  20. R. F. van Golen, T. M. van Gulik, and M. Heger, “The sterile immune response during hepatic ischemia/reperfusion,” Cytokine & Growth Factor Reviews, vol. 23, no. 3, pp. 69–84, 2012. View at Google Scholar
  21. A. Pratap, R. Panakanti, N. Yang et al., “Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers,” Molecular Pharmaceutics, vol. 8, no. 3, pp. 958–968, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Jaeschke and T. Hasegawa, “Role of neutrophils in acute inflammatory liver injury,” Liver International, vol. 26, no. 8, pp. 912–919, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Vollmar, S. Richter, and M. D. Menger, “Liver ischemia/reperfusion induces an increase of microvascular leukocyte flux, but not heterogeneity of leukocyte trafficking,” Liver, vol. 17, no. 2, pp. 93–98, 1997. View at Google Scholar · View at Scopus
  24. K. B. Walsh, A. H. Toledo, F. A. Rivera-Chavez, F. Lopez-Neblina, and L. H. Toledo-Pereyra, “Inflammatory mediators of liver ischemia-reperfusion injury,” Experimental and Clinical Transplantation, vol. 7, no. 2, pp. 78–93, 2009. View at Google Scholar · View at Scopus
  25. J. H. W. Jiang Huai Wang, H. P. Redmond, R. W. G. Watson, and D. Bouchier-Hayes, “Role of lipopolysaccharide and tumor necrosis factor-α in induction of hepatocyte necrosis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 269, no. 2, part 1, pp. G297–G304, 1995. View at Google Scholar · View at Scopus
  26. W. Lee, E. J. Yang, S. K. Ku, K. S. Song, and J. S. Bae, “Anti-inflammatory effects of oleanolic acid on LPS-induced inflammation in vitro and in vivo,” Inflammation, vol. 36, no. 1, pp. 94–102, 2013. View at Google Scholar
  27. S. A. Reisman, L. M. Aleksunes, and C. D. Klaassen, “Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes,” Biochemical Pharmacology, vol. 77, no. 7, pp. 1273–1282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. T. J. Cremer, D. H. Ravneberg, C. D. Clay et al., “MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response,” PLoS ONE, vol. 4, no. 12, Article ID e8508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Fukao and S. Koyasu, “PI3K and negative regulation of TLR signaling,” Trends in Immunology, vol. 24, no. 7, pp. 358–363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. L. Williams, T. Ozment-Skelton, and C. Li, “Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury,” Shock, vol. 25, no. 5, pp. 432–439, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-P. Yu, S.-C. Yang, Y.-T. Lau, and T.-L. Hwang, “Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage,” Surgery, vol. 148, no. 1, pp. 103–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Müller, F. Dünschede, E. Koch, A. M. Vollmar, and A. K. Kiemer, “α-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 285, no. 4, pp. G769–G778, 2003. View at Google Scholar · View at Scopus
  33. Z. Cai and G. L. Semenza, “Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury,” Circulation, vol. 109, no. 17, pp. 2050–2053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Hazeki, K. Nigorikawa, and O. Hazeki, “Role of phosphoinositide 3-kinase in innate immunity,” Biological and Pharmaceutical Bulletin, vol. 30, no. 9, pp. 1617–1623, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Rehani, H. Wang, C. A. Garcia, D. F. Kinane, and M. Martin, “Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/21,” Journal of Immunology, vol. 182, no. 1, pp. 547–553, 2009. View at Google Scholar · View at Scopus
  36. N. Kamada, N. Kanaya, N. Hirata, S. Kimura, and A. Namiki, “Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3β,” Canadian Journal of Anesthesia, vol. 55, no. 9, pp. 595–605, 2008. View at Publisher · View at Google Scholar · View at Scopus